Condition: Lymphoblastic Leukemia in Children · Sponsor: Hee Young Ju
Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for high risk acute lymphoblastic leukemia in children and adolescents.
This description comes directly from the study's public registry record.
Hee Young Ju, MD, Phd · 82-2-3410-0865 · heeyoung.ju@samsung.com
hyunjung Shin · 82-2-3410-6763 · hjds.shin@samsung.com
Always discuss trial participation with your own doctor first.
| Asan Medical Center | Seoul, Other (Non U.s.), South Korea | Recruiting |
| Samsung Medical Center | Seoul, Other (Non U.s.), South Korea | Recruiting |
| Pusan National University Yangsan Hospital | Yangsan, Yangsan-si, South Korea | Recruiting |
| Chonnam National University Hwasun Hospital | Hwasun, South Korea | Not Yet Recruiting |
| Jeju National University Hospital | Jeju City, South Korea | Not Yet Recruiting |
| Korea University Anam Hospital | Seoul, South Korea | Not Yet Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| Severance Hospital | Seoul, South Korea | Recruiting |
| Seoul saint Mary's Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06099366